TL4-12 是一种选择性 MAP4K2/GCK 抑制剂,下调 IKZF1 和 BCL-6,并抑制 MM 细胞增殖 (IC50=37 nM) 并诱导细胞凋亡。TL4-12 可用于克服多发性骨髓瘤 (MM) 中免疫调节剂的耐药性。
All
Chemical Reagents
Biomedicine
Organic raw materials
Inorganic chemical industry
intermediate
Agricultural chemicals
Auxiliaries and catalysts
Fragrances and Flavors
Dyes and Pigments
Daily chemical industry
TL4-12
CAS number:1620820-12-3 molecular formula:C25H27F3N6O2
overview
compound introduction
Specs
| Chinese alias | 4-甲基-3-[[[6-(甲基氨基)-4-嘧啶基]氧基] -N-[3-(4-甲基-1-哌嗪基)-5-(三氟甲基)苯基]苯甲酰胺 | ||
| English alias | 4-Methyl-3-[[6-(methylamino)-4-pyrimidinyl]oxy]-N-[3-(4-methyl-1-piperazinyl)-5-(trifluoromethyl)phenyl]benzamide | ||
| CAS number | 1620820-12-3 | molecular formula | C25H27F3N6O2 |
| molecular weight | 500.53 g/mol | Exact mass | ≥96%(HPLC) |
| PSA | - | logp | - |
numbering system
No numbering system information yet
physicochemical properties
No physical and chemical property information yet
Safety information
No safety information yet
Production methods and uses
No production method and use information yet
Related
upstream information
No upstream information yet
downstream information
No downstream information yet
MSDS
Found 0 shareMSDS





